Literature DB >> 17174093

IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation.

Giovanni Paganelli1, Mahila Ferrari, Marta Cremonesi, Concetta De Cicco, Viviana Galimberti, Alberto Luini, Paolo Veronesi, Maurizio Fiorenza, Paolo Carminati, Claudio Zanna, Roberto Orecchia, Umberto Veronesi.   

Abstract

A new procedure, known as Intraoperative Avidination for Radionuclide Therapy (IART), is described in breast cancer patients. In this paper, we provide proof of the principle that intraoperative injection of avidin in the tumour bed after quadrantectomy allows homing in of intravenously (IV) administered radioactive biotin to the target site. This approach of targeted therapy consists of two steps: (i) "avidination" of the anatomical area of the tumour with avidin injected by the surgeon, into and around the tumour bed; (ii) targeting the anatomical area of the tumour by IV injection of radiolabelled biotin. The scintigraphic images demonstrated fast and stable uptake of labelled biotin at the site of operated breast. The radiation dose released to the index quadrant was more than 5 Gy/GBq, consistent with a boost of 20 Gy for an activity of 3.7 GBq 90Y-biotin (100mCi). A further large clinical trial facing IART in combination with reduced external-beam radiotherapy is, in our opinion, fully justified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174093     DOI: 10.1016/j.breast.2006.10.003

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  12 in total

1.  Breast Cancer Surgery - a Forecast.

Authors:  Alberto Costa
Journal:  Breast Care (Basel)       Date:  2008-12-02       Impact factor: 2.860

2.  3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy.

Authors:  Mahila E Ferrari; Marta Cremonesi; Amalia Di Dia; Francesca Botta; Concetta De Cicco; Anna Sarnelli; Piernicola Pedicini; Michele Calabrese; Roberto Orecchia; Guido Pedroli; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-14       Impact factor: 9.236

3.  Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.

Authors:  Giovanni Paganelli; Concetta De Cicco; Mahila E Ferrari; Giuseppe Carbone; Gianmatteo Pagani; Maria Cristina Leonardi; Marta Cremonesi; Annamaria Ferrari; Monica Pacifici; Amalia Di Dia; Rita De Santis; Viviana Galimberti; Alberto Luini; Roberto Orecchia; Stefano Zurrida; Umberto Veronesi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-04       Impact factor: 9.236

4.  Biochemical and biological characterization of a new oxidized avidin with enhanced tissue binding properties.

Authors:  Antonio Verdoliva; Piero Bellofiore; Vincenzo Rivieccio; Sergio Catello; Maurizio Colombo; Claudio Albertoni; Antonio Rosi; Barbara Leoni; Anna Maria Anastasi; Rita De Santis
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

5.  IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin.

Authors:  G Paganelli; C De Cicco; M E Ferrari; G McVie; G Pagani; M C Leonardi; M Cremonesi; A Ferrari; M Pacifici; A Di Dia; F Botta; R De Santis; V Galimberti; A Luini; R Orecchia; U Veronesi
Journal:  Ecancermedicalscience       Date:  2010-11-01

6.  AvidinOX-anchored biotinylated trastuzumab and pertuzumab induce down-modulation of ErbB2 and tumor cell death at concentrations order of magnitude lower than not-anchored antibodies.

Authors:  Ferdinando Maria Milazzo; Anna Maria Anastasi; Caterina Chiapparino; Antonio Rosi; Barbara Leoni; Loredana Vesci; Fiorella Petronzelli; Rita De Santis
Journal:  Oncotarget       Date:  2017-04-04

Review 7.  Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO).

Authors:  Giovanni Paganelli
Journal:  Ecancermedicalscience       Date:  2017-06-08

Review 8.  Therapeutic Applications of Pretargeting.

Authors:  Marjolein Verhoeven; Yann Seimbille; Simone U Dalm
Journal:  Pharmaceutics       Date:  2019-09-01       Impact factor: 6.321

Review 9.  Imaging and cancer: a review.

Authors:  Leonard Fass
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 7.449

Review 10.  Radionuclide carriers for targeting of cancer.

Authors:  Stavroula Sofou
Journal:  Int J Nanomedicine       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.